Aureka Biotechnologies: Funding, Investors & Team (Sep 2026)
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Aureka Biotechnologies has raised $135M across 2 funding rounds on record, the most recent a Series B of $100M announced in Aug 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aureka Biotechnologies Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Aureka Biotechnologies Funding Rounds
Aureka Biotechnologies raised $35.0M in a Series A announced in Apr 2026.
4 months later, a Series B of $100M was announced in Aug 2026.
Aureka Biotechnologies Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Aureka Biotechnologies Founders and Leadership Team
Contact details for the Aureka Biotechnologies team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Aureka Biotechnologies Funding Compared to Other Biotechnology Startups
Aureka Biotechnologies' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aureka Biotechnologies in Biotechnology and Laguna Hills
Companies Similar to Aureka Biotechnologies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Aureka Biotechnologies Funding FAQs
What does Aureka Biotechnologies do?
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
How much funding has Aureka Biotechnologies raised?
Aureka Biotechnologies has raised $135M across 2 rounds on record. The most recent is a Series B of $100M announced in Aug 2026.
When did Aureka Biotechnologies last raise funding?
Aureka Biotechnologies' most recent funding round on record is a Series B of $100M, announced in Aug 2026.
Who has invested in Aureka Biotechnologies?
Investors on record for Aureka Biotechnologies include Matrix Partners China, Qiming Venture Partners, Granite Asia, 5Y Capital, HongShan. FundedIQ records 10 investors in total.
Who founded Aureka Biotechnologies?
FundedIQ lists Alon Wellner (VP Biology and Co-founder), Weian Zhao (Founder) at Aureka Biotechnologies.
Where is Aureka Biotechnologies headquartered?
Aureka Biotechnologies is based in Laguna Hills, California, United States.
How many employees does Aureka Biotechnologies have?
Aureka Biotechnologies is in the 11-50 employee band.
When was Aureka Biotechnologies founded?
Aureka Biotechnologies was founded in 2023.
How does Aureka Biotechnologies' funding compare to other Biotechnology startups?
Aureka Biotechnologies' latest round of $100M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Aureka Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aureka Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.